Amazing how a buyout of a company with a promising cancer drug can affect the perception of GERN and its cancer drug IMET! Here's to hoping for a blockbuster with many indications!
Got a love it! Not sure what it means other than the shorts are nervous and folks are accumulating! You gotta have balls of steel to be short this thing now. Only those on the inside know what really is going on, but we may not have to wait as long as I thought, to start to see some of the value of this company unlocked in the share price!
you are right! My bad on that! Still wacko koko, I need u to answer me. What event does it take to get these shorts to cover?
You did not answer my question. WHAT IS IT GOING TO TAKE FOR THE SHORTS TO COVER? Do we have to hear a buyout announced? Do we need the phase two data announced? You see, the more we get no news, the longer this BS goes on! Also, as already pointed out, we got the partnership with Jansen and the stock made a small move and then retrenched! So even good solid news has not moved this thing!
Hey KoKo, what exactly is it going to take for these shorts to cover? How many positive developments do we need before they get scared and cover? I like your thesis, but why hasn't the stock recovered? This is potentially a big deal, a promising drug that has caused remissions in cancer! Big Pharma needs drugs like IMET to improve their struggling pipelines. With PCYC getting bought recently, looks like some of the shorts got nervous. But, when you short a 3 dollar stock, you are betting on failure, because all you can get on the downside is the 3 bills while if you don't cover, you can lose everything if it breaks to the upside. Seems to me that , the risk of being short now is over the top, yet here we go down again, Looks like another short position taken up at $3.78 . I am a reasonable man and I sure as hell would not be short right now. Maybe, just maybe, you should consider what black is saying. Something just does not add up here. I am long with just a few thousand wrapped up in this thing, but I would not want to be all in on this either, because something is rotten. This stock should trade right now at 7-8 dollars simply based on what is known!
This might actually happen! However, you have no idea when. You might be waiting a few years!
There business model is in fact to partner so as to minimize risk. I think they would like to have more data on IMET before they would make their next move. That said, what got the ball rolling yesterday was the fact that the big dog Abbvie came in and bought out Pharmacyclics taking it from Jansen before they had a chance to secure a deal.
Maybe they didn't want Pharmacyclics, but what is relevant is even if they did, they did not act quickly enough. It is this fact, that has given Geron a boost. This drug(IMET) could be a huge winner, when and if they are convinced of that, do you think they will allow some other big dog to come in and swallow up the little fish that they put a lot of time and money in, so that when it is time to reap the reward, Jansen will be left with nothing!
The happenings of yesterday, make it far less unlikely that they sit on their hands and do nothing! Big Pharma needs help with their pipelines ASAP. They are going to start gambling on promising drugs! You can bet that as soon as Jansen gets enough confirmation that IMET is going to be a big deal with multiple indications, they will be moving quickly to buy Geron and its telomerase technology at a nice premium!
What is best about this whole thing is that it could happen as soon as tomorrow!
Got that right! Greed always comes to the forefront! Those in control got tired of making money in small increments. So they finally let it go! Problem is, they could run it to 5 or more tomorrow only to sell it back to $3 next week! Ugly manipulation, you have to stay on the right side of the trade or all the big boys will take your money and leave you holding the proverbial empty bag!
here is the thing! Barron's has said that they see IMET as a billion dollar drug with multiple indications down the road! (not until the 2020's). What would GERN stand to profit given the deal in place? More importantly however, is, If data continues to come in strong, what would big companies be willing to pay to add a billion dollar drug to their pipeline? How much would Jansen(J&J) pay to protect this drug? If they are sure it is a big winner why would they not buy out GERN right now so they don't lose this drug to the likes of abbvie of some other large player who just stole pharmacyclics from them!
stop babbling! everyone already knows this. Once again, just another non-event. Do you really think that one analyst changing his forecast based on the 35 mil received is going to move this? Do not be a simpleton, hold for the real news. Not sure when it comes, but it will come! Might not be till next year even, but it will come! Maybe, it will be great news, and all your babbling will become true!
A game indeed! The longer we go without news, they are preying on people's lack of patience! They hope that each day that goes by, and the price remains low, more and more longs will panic out as they inch it lower. I admit that it is tough to sit through this period, and I have a hard time believing we get any new information soon. You just have to ask yourself, is this going to be a good story in the end? If the answer is yes, just hold and ignore all the noise!
If I may use a little poker analogy, I will try to give some clarity. Jansen, first off, is holding the cards. They are looking into their hand and have a winner. However, they could have say, 5of hearts, 6of hearts, 7 of hearts, and 8 of hearts, they are using this time right now, to see if they have a red 9, and if so, is it the 9 of hearts? The odds of a red nine are good(IMET will be a winner). The odds of the 9 of hearts i am not sure of, but, we know there is a chance(IMET is a blockbuster that has many indications for cancer).Bottom line, nobody gets to know until they see their card, and even after they see it, they may take a while to finally play the hand. We are hostage to what Jansen decides, but our odds of liking their decision and profiting from it are good. If, however, they get the 9 of hearts, some years down the road, we will all be very, very happy. Just, sit tight and hold your shares! If you are expecting some immanent news, good luck.
Wonder when the last time either of these analysts or any other for that matter, have spoken to chippy or anyone from J&J to get anything to base these targets on. It is so hush-hush out there, that the longer the silence stays in place, the more likely this old dog will come blasting off this low $3 level to maybe 2 or 3 times that! One of these days the silence will come to an end and I am hoping on that day that the longs will be very happy and the shorts will be bailing hard. Analysts price targets are more meaningless now than ever with Geron.